George Gates, MD, is a nationally recognized clinician and medical researcher in otology and is a retired otolaryngologist and neurotologist. He is an emeritus professor at the University of Washington and former director of the UW's Virginia Merrill Bloedel Hearing Research Center. During his 40-year clinical career he conducted many clinical trials, including a landmark study of the surgical treatment of chronic otitis media that was published in the New England Journal in 1987. He authored over 220 peer-reviewed published research reports, review articles, and clinical concepts in otology / neurotology.
George is the founder and chief medical officer of OtoNexus Medical Technologies, which is commercializing an ultrasound medical device to instantly and accurately diagnose middle-ear infections, or Otitis Media, in children and adults. Otitis Media is the #1 reason for antibiotic prescriptions in children and the #1 cause for surgery in children, yet clinical studies consistently show error rates in diagnosis averaging 50%.
George received his premedical education and medical training at the University of Michigan and passed his board examination in Otolaryngology in 1966. In 1971, he joined the faculty of the University of Texas Health Science Center in San Antonio and established a research-oriented training program in Otolaryngology there before moving to the University of Washington and the Bloedel Foundation. Upon retirement, he turned his efforts toward implementing ideas focused on greater precision in otologic diagnosis. He retains his emeritus professorship at the University of Washington.